awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28551075-906578A7-80F3-4291-8170-4F39EFAB6066
Q28551075-906578A7-80F3-4291-8170-4F39EFAB6066
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28551075-906578A7-80F3-4291-8170-4F39EFAB6066
A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis Patients
P2860
Q28551075-906578A7-80F3-4291-8170-4F39EFAB6066
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28551075-906578A7-80F3-4291-8170-4F39EFAB6066
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
08169506a8f3cc75754b904b35c11a7c1ea348db
P2860
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement